Penn Pharma Completes First Batch at New Site

Penn Pharma has successfully completed the first batch of coated tablets in its new contained manufacturing operation. The company built the new facility at its South Wales base this past year. The 15,000-sq.-ft. site was built for the clinical and commercial manufacture of tablets and capsules.
 
Penn Pharma’s chief executive officer, Richard Yarwood, said, “It is a monumental day for Penn Pharma, in less than one year we have built a world-class facility for contained manufacturing and produced our first batch of coated tablets. This gives our customers even greater confidence that Penn Pharma can meet the challenging timelines they require to get their products to market.”